Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study - Concepedia

Concepedia

Publication | Closed Access

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study

128

Citations

16

References

2014

Year

Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, Richard David Leslie, Xiangbing Wang, Zhiguang Zhou

The Journal of Clinical Endocrinology & Metabolism

Abstract

LADA patients treated with sitagliptin and insulin maintained β-cell function by comparison with insulin alone.

References

	Year	Citations

Page 1